ALPHA PRO TECH LTD APT

Healthcare SIC 3842 - Orthopedic, Prosthetic & Surgical Appliances & Supplies NAICS Manufacturing › Miscellaneous Manufacturing › Medical Equipment and Supplies Manufacturing › Surgical Appliance and Supplies Manufacturing derived NYSE

ALPHA PRO TECH, LTD. ("Alpha Pro Tech," the "Company," "we," "our" or "us") is the parent company of Alpha Pro Tech, Inc. and Alpha ProTech Engineered Products, Inc. The Company was incorporated in the State of Delaware on July 1, 1994, as a successor to a business that was organized in 1983. Our executive offices are located at 53 Wellington Street East, Aurora, Ontario, Canada L4G 1H6, and our telephone number is (905) 479-0654. Our website is located at www.alphaprotech.com.

The Company continued to qualify as a smaller reporting company at the measurement date for determining such qualification during 2025. According to the disclosure requirements for smaller reporting companies, the Company has included consolidated balance sheets as of December 31, 2025 and 2024, and consolidated statements of income, comprehensive income, shareholders' equity and cash flows for each of the two years in the period ended December 31, 2025.

Last close 5.56 2026-10-23
Market cap $56.7M 2026-06-30 share count
52-week range 4.34 - 7.50

Valuation FY2025 figures against the last close

P/S1.0x
P/E16.8x
P/FCF32.8x
EV/EBITDA11.9x
Dividend yield—
Diluted EPS0.33

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $59.1M$57.8M$61.2M$62.0M$68.6M$102.7M$46.7M$46.6M$44.0M$46.2M
Cost of revenue $36.6M$34.9M$38.4M$40.3M$43.3M$52.2M$29.7M$28.9M$26.6M$29.2M
Gross profit $22.5M$22.9M$22.8M$21.7M$25.3M$50.5M$17.0M$17.7M$17.5M$17.0M
R&D ————————$0$0
SG&A $17.8M$18.6M$17.8M$16.2M$16.6M$18.2M$13.3M$13.3M$14.0M$12.8M
Total operating expenses $18.7M$19.5M$18.7M$17.0M$17.4M$18.9M$13.9M$13.8M$14.5M$13.3M
Operating income $3.8M$3.4M$4.1M$4.7M$7.9M$31.6M$3.0M$3.9M$2.9M$3.7M
Pre-tax income $4.6M$5.0M$5.4M$4.4M$8.5M$32.2M$3.7M$4.4M$3.7M$4.2M
Income tax $1.1M$1.1M$1.2M$1.1M$1.7M$5.4M$680.0K$789.0K$1.0M$1.0M
Net income $3.5M$3.9M$4.2M$3.3M$6.8M$26.9M$3.0M$3.6M$2.6M$3.2M
EPS, basic 0.340.350.350.260.512.000.230.260.180.19
EPS, diluted 0.330.350.350.260.501.920.230.260.180.19
Shares, diluted (wtd. avg.) 10.6M11.2M11.9M12.8M13.5M14.0M13.2M14.0M15.0M16.8M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $17.0M$18.6M$20.4M$16.3M$16.3M$23.3M$6.5M$7.0M$8.8M$9.5M
Receivables ———$5.4M$3.4M$8.1M$3.6M$4.9M$4.6M$4.6M
Inventory $23.6M$22.7M$20.1M$24.4M$25.0M$16.7M$11.3M$9.9M$10.2M$11.0M
Total current assets $52.5M$50.6M$53.1M$52.6M$53.0M$55.2M$26.1M$26.5M$27.0M$29.7M
Property, plant and equipment $8.2M$8.5M$5.6M$5.7M$6.1M$4.4M$3.9M$3.2M$3.2M$2.6M
Goodwill $55.0K$55.0K$55.0K$55.0K$55.0K$55.0K$55.0K$55.0K$55.0K$55.0K
Other intangibles ——$0$1.0K$3.0K$7.0K$11.0K$16.0K$21.0K$34.0K
Total assets $74.1M$73.7M$68.8M$64.8M$66.8M$67.57B$38.1M$34.3M$34.1M$35.9M
Accounts payable $2.0M$1.3M$802.0K$674.0K$528.0K$2.0M$501.0K$578.0K$1.2M$1.0M
Total current liabilities $4.1M$3.1M$2.6M$2.4M$2.7M$5.9M$2.3M$1.9M$2.8M$2.5M
Total liabilities $11.7M$11.5M$7.2M$4.0M$5.3M$9.1M$4.9M$2.1M$2.8M$3.3M
Retained earnings $48.5M$47.3M$46.6M$45.4M$45.4M$61.65B$32.4M$29.4M$26.2M$22.7M
Total equity $62.5M$62.2M$61.6M$60.8M$61.8M$58.8M$32.9M$32.2M$31.3M$32.7M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $2.4M$5.7M$8.5M$4.3M-$480.0K$18.3M$3.1M$2.0M$4.0M$6.8M
Depreciation and amortisation $925.0K$873.0K$925.0K$814.0K$817.0K$729.0K$602.0K$525.0K$571.0K$544.0K
Stock-based compensation $540.0K$463.0K$170.0K$147.0K$315.0K$375.0K$451.0K$432.0K$296.0K$190.0K
Capital expenditure $639.0K$3.8M$792.0K$492.0K$2.5M$1.1M$1.3M$606.0K$1.2M$267.0K
Investing cash flow -$639.0K-$3.8M-$792.0K—-$2.5M-$862.0K-$1.1M-$570.0K-$685.0K-$308.0K
Financing cash flow -$3.4M-$3.7M-$3.6M-$3.8M-$4.0M-$668.0K-$2.4M-$3.2M-$4.0M-$6.8M
Buybacks $3.3M$4.5M$4.0M$3.9M$4.4M$2.7M$2.5M$3.6M$4.2M$6.8M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001437749-26-014020.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 50M 100M 150M Revenue, FY2016: 46.2M Gross profit, FY2016: 17M Net income, FY2016: 3.2M Revenue, FY2017: 44M Gross profit, FY2017: 17.5M Net income, FY2017: 2.6M Revenue, FY2018: 46.6M Gross profit, FY2018: 17.7M Net income, FY2018: 3.6M Revenue, FY2019: 46.7M Gross profit, FY2019: 17M Net income, FY2019: 3M Revenue, FY2020: 102.7M Gross profit, FY2020: 50.5M Net income, FY2020: 26.9M Revenue, FY2021: 68.6M Gross profit, FY2021: 25.3M Net income, FY2021: 6.8M Revenue, FY2022: 62M Gross profit, FY2022: 21.7M Net income, FY2022: 3.3M Revenue, FY2023: 61.2M Gross profit, FY2023: 22.8M Net income, FY2023: 4.2M Revenue, FY2024: 57.8M Gross profit, FY2024: 22.9M Net income, FY2024: 3.9M Revenue, FY2025: 59.1M Gross profit, FY2025: 22.5M Net income, FY2025: 3.5M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $46.2M $44.0M $46.6M $46.7M $102.7M $68.6M $62.0M $61.2M $57.8M $59.1M
Gross profit $17.0M $17.5M $17.7M $17.0M $50.5M $25.3M $21.7M $22.8M $22.9M $22.5M
Net income $3.2M $2.6M $3.6M $3.0M $26.9M $6.8M $3.3M $4.2M $3.9M $3.5M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Results announced Item 2.02
  • Results announced Item 2.02
  • Shareholder vote Item 5.07
  • Results announced Item 2.02
  • Annual report filed Form 10-K
  • Results announced Item 2.02
  • Results announced Item 2.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 3842

TickerCompanyMarket capP/ERevenue growth
ISRG INTUITIVE SURGICAL INC $159.78B 57.5x 20.5%
EW Edwards Lifesciences Corp $51.34B 48.7x 11.5%
STE STERIS plc $22.63B 29.3x 8.7%
ZBH ZIMMER BIOMET HOLDINGS, INC. $18.80B 27.8x 7.2%
ALGN ALIGN TECHNOLOGY INC $10.98B 27.3x 0.9%
MSA MSA Safety Inc $7.03B 25.7x 3.7%
ESTA ESTABLISHMENT LABS HOLDINGS INC. $1.90B — 27.1%
CDRE Cadre Holdings, Inc. $1.28B 29.4x 7.5%